Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
01/29/1997 | EP0755454A1 Aav-mediated delivery of dna to cells of the nervous system |
01/29/1997 | EP0755443A1 Tissue-specific enhancer active in prostate |
01/29/1997 | EP0755441A1 Antibacterial therapy with genotypically modified bacteriophage |
01/29/1997 | EP0755439A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process |
01/29/1997 | EP0755402A1 Alpha(1,3) galactosyltransferase negative swine |
01/29/1997 | EP0755259A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
01/29/1997 | EP0755258A1 Methods of treating disease using sertoli cells and allografts or xenografts |
01/29/1997 | EP0755257A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
01/29/1997 | EP0755186A1 Agent having a protective action against attack by insects or parasites as well as an anti-inflammatory action |
01/29/1997 | EP0673256A4 Suppression of myeloid cells. |
01/29/1997 | EP0641183A4 Coated transplant and method for making same. |
01/29/1997 | CN1141650A Macroencapsulated secretory cells |
01/29/1997 | CN1141191A Styracol tablet |
01/29/1997 | CN1141184A Method of preparing medicated wine for treating injury and setting bone |
01/29/1997 | CN1141171A Biological prepn. and method for preparing same |
01/29/1997 | CN1033896C "Xiangjiachongji" Chinese herb medicinal granule for treating hyerprolactinemia disease |
01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
01/28/1997 | US5597585 Nutritional mixture in the form of a dry water-soluble powder optionally containing ethylenediamine tetraacetic acid |
01/28/1997 | US5597572 Method of producing Neisseria meningitidis B vaccine, and vaccine produced by method |
01/28/1997 | US5597570 Protein recognized by antibodies raised against native P28 of schistosoma mansoni |
01/28/1997 | US5597563 Depletion of thymic antigen presenting cells |
01/28/1997 | US5597558 Use of extracts of filamentous bacteria as cosmetic agents to combat ageing of the skin |
01/28/1997 | US5597488 Method for preparing various thermal waters |
01/23/1997 | WO1997002421A1 Pumping device |
01/23/1997 | WO1997002355A1 Recombinant mva virus, and the use thereof |
01/23/1997 | WO1997002354A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
01/23/1997 | WO1997002344A2 Vaccine for infectious agents, composition for treating and preventing hiv infections |
01/23/1997 | WO1997002049A1 Neuronal progenitor cells and uses thereof |
01/23/1997 | WO1997002040A1 Terpene-based pharmaceutical product |
01/23/1997 | WO1996040945A3 Nucleic acid respiratory syncytial virus vaccines |
01/23/1997 | CA2226417A1 Neuronal progenitor cells and uses thereof |
01/23/1997 | CA2224940A1 Interaction of p53 with transcription factor dp-1 |
01/23/1997 | CA2223825A1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
01/22/1997 | EP0754699A1 Completely dissolved bone tissue and method for producing the same |
01/22/1997 | EP0754462A2 Auxiliary liver with long term storability and production thereof |
01/22/1997 | EP0754461A2 A preservation solution of blood platelets |
01/22/1997 | EP0754052A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
01/22/1997 | EP0684867A4 Blood filter and method of manufacturing filter. |
01/22/1997 | EP0684866A4 Filtration media and device for filtering leukocytes. |
01/22/1997 | EP0524971B1 Decontaminated biological material |
01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
01/22/1997 | CN1141058A In situ modification and manipulation of stem cells of the central nervous system |
01/22/1997 | CN1140602A Medicine for treatment of tuberculosis |
01/22/1997 | CN1140601A Traditional-Chinese-medicines antiphthitic preparation |
01/22/1997 | CN1140588A "Shuganmei" medicine for treatment of liver disease and its preparation |
01/22/1997 | CN1140587A Ant and snake compound capsule |
01/22/1997 | CN1033864C Emulsifying method for bee products and wines |
01/22/1997 | CN1033839C Processing method for binding-inducing composition |
01/21/1997 | US5595974 Batroxobin with heparin for cardiovascular disorders |
01/21/1997 | US5595909 Filter device |
01/21/1997 | US5595885 Matrix metalloproteinase inhibitor peptides |
01/21/1997 | US5595881 Method for the detection of antigen presenting cells |
01/21/1997 | US5595866 Protective coating removed by swelling |
01/21/1997 | US5595745 Cosmetics; petroleum jelly and behenoyl lactylate salt |
01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
01/16/1997 | WO1997001358A1 Tissue specific viral vectors |
01/16/1997 | WO1997001357A1 Encapsulated cells producing viral particles |
01/16/1997 | WO1997001336A1 Use of lamellarin-class alkaloids in methods of treatment |
01/16/1997 | DE19525784A1 Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) Autoreactive peptides from human glutamic acid decarboxylase (GAD) |
01/16/1997 | CA2222559A1 Encapsulated cells producing viral particles |
01/16/1997 | CA2222457A1 Tissue specific viral vectors |
01/15/1997 | EP0753313A1 Skin substitute using marine organisms |
01/15/1997 | EP0753304A1 Thrombolytic enzyme and method of obtaining same |
01/15/1997 | EP0753303A2 Physiologically functional food having brain function-improving, learning ability-enhancing, and memory-enhancing functions |
01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
01/15/1997 | EP0753068A1 Ligands added to adenovirus fiber |
01/15/1997 | EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
01/15/1997 | EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
01/15/1997 | EP0753055A1 Enzymatic antimicrobial compositions |
01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
01/15/1997 | EP0752904A1 Body fluid filtration device and application thereof |
01/15/1997 | EP0752882A1 Treatment for juvenile diabetes |
01/15/1997 | EP0752881A1 A novel brain endothelial cell protein and methods for its use |
01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
01/15/1997 | EP0752870A1 Immunotherapeutic agent and its use |
01/15/1997 | EP0752869A1 Cells with multiple altered epitopes on a surface antigen for use in transplantation |
01/15/1997 | EP0752868A1 Improved methods for transplantation using modified cells and t cell inhibitory agents |
01/15/1997 | EP0752867A1 Selective cell proliferation |
01/15/1997 | EP0752849A1 Heme-bearing microparticles for targeted delivery of drugs |
01/15/1997 | EP0652777A4 Small animal metastasis model. |
01/15/1997 | EP0440742B1 Liposome immunoadjuvants containing il-2 |
01/15/1997 | CN1140410A Vitamin E and derivs. preventing damage in red cells sterilized by phthalocyanines and light |
01/15/1997 | CN1140089A Oral liquid of collagen protein and preparing process thereof |
01/15/1997 | CN1140087A Liquid medicine for treatment of tracheitis and preparing method thereof |
01/15/1997 | CN1140086A Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome |
01/15/1997 | CN1140084A Medicine for treatment of diabetes mellitus and its preparing process |
01/15/1997 | CN1140080A Stomach-recovering capsule |
01/15/1997 | CN1140071A Anticancer drug and preparing method thereof |
01/15/1997 | CN1140062A Habit-breaking acupoint adhesive plaster for smokers |
01/15/1997 | CN1140060A "Guibiewang" tortoise turtle capsule and preparing method thereof |
01/14/1997 | US5594032 Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
01/14/1997 | US5593876 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
01/14/1997 | US5593698 Immunosuppressants |
01/14/1997 | US5593697 Single dose vaccination system |
01/14/1997 | US5593673 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
01/14/1997 | CA2082952C Color modified melanins and methods for their preparation and use |
01/09/1997 | WO1997000957A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
01/09/1997 | WO1997000947A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
01/09/1997 | WO1997000694A1 A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
01/09/1997 | WO1997000691A1 Modulation of endothelial cell proliferation |